Directorate Change

FINSBURY WORLDWIDE PHARMACEUTICALTRUST PLC                   

                         APPOINTMENT OF NEW DIRECTORS                          

The Board of the Company is delighted to announce the appointment of two new
directors to the Company with immediate effect.

Dr David Holbrook, is a qualified physician and Life Sciences Partner at MTI
Partners Limited, a leading technology venture capital investor. He attended
London and Oxford Universities, and has an MBA from Harvard Business School. He
has held senior positions in a number of blue-chip biopharmaceutical
organisations including GlaxoSmithKline and Roche.

Martin Smith, is a non executive director of New Star Asset Management Group
PLC. He attended Oxford University and has an MBA from Stanford University. He
was a founder of Phoenix Securities, a private investment banking firm.
Following the acquisition of Phoenix in 1997 by Donaldson Lufkin and Jenrette
(DLJ), he chaired DLJ's European Investment Banking Group. Previously he worked
at Citicorp and Bankers Trust.

There are no matters to be disclosed under listing rule 9.6.13.

For and on behalf of the Board

Frostrow Capital LLP

Company Secretary

8 November 2007

For further information please contact:

Ian Ivory, Chairman, Finsbury Worldwide Pharmaceutical Trust PLC 01828 640383

Alastair Smith, Frostrow Capital LLP 0203 008 4911